Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment

Author: Tinazzi Elisa   Puccetti Antonio   Gerli Roberto   Rigo Antonella   Migliorini Paola   Simeoni Sara   Beri Ruggero   Dolcino Marzia   Martinelli Nicola   Corrocher Roberto   Lunardi Claudio  

Publisher: Oxford University Press

ISSN: 1460-2377

Source: International Immunology, Vol.21, Iss.3, 2009-03, pp. : 237-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract